Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome

  Free Subscription


26.08.2019

1 Adv Med Educ Pract
1 Am J Ther
1 BMJ Open
2 Clin Gastroenterol Hepatol
1 Dtsch Arztebl Int
1 Gut
1 Immun Inflamm Dis
1 J Complement Integr Med
1 J Food Prot
1 J Gastroenterol
1 J Psychiatr Res
1 JPEN J Parenter Enteral Nutr
1 Med Hypotheses
1 Microorganisms
1 Neurogastroenterol Motil
3 Nutrients
1 PLoS One
1 Sci Rep
1 Therap Adv Gastroenterol
1 Trials
2 United European Gastroenterol J
1 West J Nurs Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Med Educ Pract

  1. MAHMOUDI L, Shafiekhani M, Dehghanpour H, Niknam R, et al
    Community pharmacists' knowledge, attitude, and practice of Irritable Bowel Syndrome (IBS): the impact of training courses.
    Adv Med Educ Pract. 2019;10:427-436.
    PubMed     Text format     Abstract available


    Am J Ther

  2. STEFAN-LUCIAN P, Giuseppe C, Liliana D, Dan Lucian D, et al
    The Efficacy of Hypnotherapy in the Treatment of Functional Dyspepsia.
    Am J Ther. 2019 Jul 9. doi: 10.1097/MJT.0000000000001033.
    PubMed     Text format     Abstract available


    BMJ Open

  3. KEATING JA, Shaughnessy C, Baubie K, Kates AE, et al
    Characterising the gut microbiome in veterans with Gulf War Illness: a protocol for a longitudinal, prospective cohort study.
    BMJ Open. 2019;9:e031114.
    PubMed     Text format     Abstract available


    Clin Gastroenterol Hepatol

  4. BALLOU S, McMahon C, Lee HN, Katon J, et al
    Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey.
    Clin Gastroenterol Hepatol. 2019 Aug 13. pii: S1542-3565(19)30891.
    PubMed     Text format     Abstract available

  5. SINGH P, Lee HN, Rangan V, Ballou S, et al
    Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea.
    Clin Gastroenterol Hepatol. 2019 Aug 20. pii: S1542-3565(19)30895.
    PubMed     Text format     Abstract available


    Dtsch Arztebl Int

  6. HAUSER W, Marschall U, Layer P, Grobe T, et al
    The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome.
    Dtsch Arztebl Int. 2019;116.
    PubMed     Text format     Abstract available


    Gut

  7. MISSELWITZ B, Butter M, Verbeke K, Fox MR, et al
    Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management.
    Gut. 2019 Aug 19. pii: gutjnl-2019-318404. doi: 10.1136/gutjnl-2019-318404.
    PubMed     Text format     Abstract available


    Immun Inflamm Dis

  8. HYLAND ME, Lanario JW, Wei Y, Jones RC, et al
    Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia.
    Immun Inflamm Dis. 2019 Aug 23. doi: 10.1002.
    PubMed     Text format     Abstract available


    J Complement Integr Med

  9. DERAKHSHANDE P, Navabi SJ, Shokoohinia Y, Rouhi-Broujeni H, et al
    Efficacy and safety of Achillea wilhelmsii C. Koch capsules on symptom severity and quality of life in patients with irritable bowel syndrome: a randomized, placebo-controlled clinical trial.
    J Complement Integr Med. 2019.
    PubMed     Text format     Abstract available


    J Food Prot

  10. FORD L, Haywood P, Kirk MD, Lancsar E, et al
    Cost of Salmonella Infections in Australia, 2015.
    J Food Prot. 2019 Aug 22:1607-1614. doi: 10.4315/0362.
    PubMed     Text format     Abstract available


    J Gastroenterol

  11. KAWAMURA Y, Yamamoto S, Funaki Y, Ohashi W, et al
    Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
    J Gastroenterol. 2019 Aug 19. pii: 10.1007/s00535-019-01611.
    PubMed     Text format     Abstract available


    J Psychiatr Res

  12. TURNA J, Grosman Kaplan K, Patterson B, Bercik P, et al
    Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder.
    J Psychiatr Res. 2019;118:1-6.
    PubMed     Text format     Abstract available


    JPEN J Parenter Enteral Nutr

  13. KORETZ RL
    JPEN Journal Club 47. How Good Should Evidence Be?
    JPEN J Parenter Enteral Nutr. 2019 Aug 18. doi: 10.1002/jpen.1684.
    PubMed     Text format    


    Med Hypotheses

  14. UNO Y
    Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease.
    Med Hypotheses. 2019;132:109324.
    PubMed     Text format     Abstract available


    Microorganisms

  15. MCLEOD A, Fagerlund A, Rud I, Axelsson L, et al
    Large Plasmid Complement Resolved: Complete Genome Sequencing of Lactobacillus plantarum MF1298, a Candidate Probiotic Strain Associated with Unfavorable Effect.
    Microorganisms. 2019;7.
    PubMed     Text format     Abstract available


    Neurogastroenterol Motil

  16. DAVYDOV DM, Shahabi L, Naliboff B
    Cardiovascular phenotyping for personalized lifestyle treatments of chronic abdominal pain in Irritable Bowel Syndrome: A randomized pilot study.
    Neurogastroenterol Motil. 2019 Aug 20:e13710. doi: 10.1111/nmo.13710.
    PubMed     Text format     Abstract available


    Nutrients

  17. CATINEAN A, Neag AM, Nita A, Buzea M, et al
    Bacillus spp. Spores-A Promising Treatment Option for Patients with Irritable Bowel Syndrome.
    Nutrients. 2019;11.
    PubMed     Text format     Abstract available

  18. IBRAHIM F, Stribling P
    A 5Ad Dietary Protocol for Functional Bowel Disorders.
    Nutrients. 2019;11.
    PubMed     Text format     Abstract available

  19. DIETERICH W, Zopf Y
    Gluten and FODMAPS-Sense of a Restriction/When Is Restriction Necessary?
    Nutrients. 2019;11.
    PubMed     Text format     Abstract available


    PLoS One

  20. PENDEGRAFT AH, Guo B, Yi N
    Bayesian hierarchical negative binomial models for multivariable analyses with applications to human microbiome count data.
    PLoS One. 2019;14:e0220961.
    PubMed     Text format     Abstract available


    Sci Rep

  21. MADEMPUDI RS, Ahire JJ, Neelamraju J, Tripathi A, et al
    Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults.
    Sci Rep. 2019;9:12210.
    PubMed     Text format     Abstract available


    Therap Adv Gastroenterol

  22. SERRANO-FALCON B, Delgado-Aros S, Mearin F, Ciriza de Los Rios C, et al
    Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms.
    Therap Adv Gastroenterol. 2019;12:1756284819857358.
    PubMed     Text format     Abstract available


    Trials

  23. GUNN D, Fried R, Lalani R, Farrin A, et al
    Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial.
    Trials. 2019;20:517.
    PubMed     Text format     Abstract available


    United European Gastroenterol J

  24. HAYEE B, Watson KL, Campbell S, Simpson A, et al
    A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.
    United European Gastroenterol J. 2019;7:881-888.
    PubMed     Text format     Abstract available

  25. CLEVERS E, Tornblom H, Simren M, Tack J, et al
    Relations between food intake, psychological distress, and gastrointestinal symptoms: A diary study.
    United European Gastroenterol J. 2019;7:965-973.
    PubMed     Text format     Abstract available


    West J Nurs Res

  26. SHERWIN LB, Deroche CB, Krisanabud P, Matteson-Kome M, et al
    Adherence to Short-course Pharmacotherapy in Adults with Irritable Bowel Syndrome.
    West J Nurs Res. 2019 Aug 23:193945919872419. doi: 10.1177/0193945919872419.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: